What is it about?
The clinical spectrum of this genetic disorder
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Sheds light both on LGMD and HIV infection
Perspectives
More patients will be identified and pathomechanism understood
Prof Corrado Angelini
Universita degli Studi di Padova Polo Bibliotecario di Scienze Farmacologia e Scienze Farmaceutiche
Read the Original
This page is a summary of: LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism, Frontiers in Neurology, March 2022, Frontiers,
DOI: 10.3389/fneur.2022.840683.
You can read the full text:
Contributors
The following have contributed to this page
